1Maniotis A J, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry [J]. Am J Pathol, 1999, 155(3): 739-752.
2Sood AK, Seftor E A, Fletcher MS, et al. Molecular determinants of ovarian cancer plasticity [J]. Am J Pathol, 2001, 158(4) : 1279- 1288.
3Lee Y J, Nagai N, Siar C H, et al. Angioarchitecture of primary oral malignant melanomas [J]. J Histochem Cytochem, 2002, 50(11): 1555-1562.
4Hendrix MJ, Seftor EA, Kirschmann DA, etal. Molecularbiology of breast cancer metastasis. Molecular expression of vascular markers by aggressive breast cancer cells [J]. Breast Gancer Res, 2002, 2(6) : 417 - 422.
5Shirakawa K, Wakasugi H, Heike Y, et al. Vasculogenic mimicry and pseudo-comedo formation in breast cancer [J]. Int J Cancer, 2002, 99(6) : 821 - 828.
6Shirakawa K, Kobayashi H, Sobajima J, et al. Inflammatory breast cancer: vasculogenic mimicry and its hemodynamics of an inflammatory breast cancer xenograft model [J]. Breast Gancer Res, 2003, 5(3): 136-139.
8Buijs J T, Cleton AM, Smit V T, et al. Prognostic significance of periodic acid-Schiff positive patterns in primary breast cancer and itslymph node metastases [J]. Breast Cancer Res Treat, 2004, 84(2): 117- 130.
9WarsoM, Maniotis A J, Chen X, et al. Prognostic significance of periodic acid-Schiff positive patterns in primary cutaneous melanoma [J]. Clin Cancer Res, 2001, 7(3) : 473 - 477.
10Folberg R, HendrixMJ, Maniotis A J, et al. Vasculogenic mimicry and tumor angiogenesis [J]. Am J Pathol, 2000, 156 (2): 361 - 381.
6Su M, Feng YJ, Yao LQ, et al. Plasticity of ovarian cancer cell SK- OV3ip and vasculogenic mimicry in vivo[ J]. Int J Gynecol cancer, 2008,18 ( 3 ) :476-486.
7Carbone C, Moccia T, Zhu C, et al. Anti-VEGF trceatment-resistant pancreatic cancers secrete proinflammatory factors that contriputc to malignant progression by inducing an EMT cell phenotype[ J]. Clin Cancer Res,2011,17 ( 17 ) :5822-5832.
